Cargando…
Invited Commentary: Treatment Drop-in—Making the Case for Causal Prediction
Clinical prediction models (CPMs) are often used to guide treatment initiation, with individuals at high risk offered treatment. This implicitly assumes that the probability quoted from a CPM represents the risk to an individual of an adverse outcome in absence of treatment. However, for a CPM to co...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485150/ https://www.ncbi.nlm.nih.gov/pubmed/33595073 http://dx.doi.org/10.1093/aje/kwab030 |
_version_ | 1784577478262521856 |
---|---|
author | Sperrin, Matthew Diaz-Ordaz, Karla Pajouheshnia, Romin |
author_facet | Sperrin, Matthew Diaz-Ordaz, Karla Pajouheshnia, Romin |
author_sort | Sperrin, Matthew |
collection | PubMed |
description | Clinical prediction models (CPMs) are often used to guide treatment initiation, with individuals at high risk offered treatment. This implicitly assumes that the probability quoted from a CPM represents the risk to an individual of an adverse outcome in absence of treatment. However, for a CPM to correctly target this estimand requires careful causal thinking. One problem that needs to be overcome is treatment drop-in: where individuals in the development data commence treatment after the time of prediction but before the outcome occurs. In this issue of the Journal, Xu et al. (Am J Epidemiol. 2021;190(10):2000–2014) use causal estimates from external data sources, such as clinical trials, to adjust CPMs for treatment drop-in. This represents a pragmatic and promising approach to address this issue, and it illustrates the value of utilizing causal inference in prediction. Building causality into the prediction pipeline can also bring other benefits. These include the ability to make and compare hypothetical predictions under different interventions, to make CPMs more explainable and transparent, and to improve model generalizability. Enriching CPMs with causal inference therefore has the potential to add considerable value to the role of prediction in healthcare. |
format | Online Article Text |
id | pubmed-8485150 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-84851502021-10-01 Invited Commentary: Treatment Drop-in—Making the Case for Causal Prediction Sperrin, Matthew Diaz-Ordaz, Karla Pajouheshnia, Romin Am J Epidemiol Invited Commentary Clinical prediction models (CPMs) are often used to guide treatment initiation, with individuals at high risk offered treatment. This implicitly assumes that the probability quoted from a CPM represents the risk to an individual of an adverse outcome in absence of treatment. However, for a CPM to correctly target this estimand requires careful causal thinking. One problem that needs to be overcome is treatment drop-in: where individuals in the development data commence treatment after the time of prediction but before the outcome occurs. In this issue of the Journal, Xu et al. (Am J Epidemiol. 2021;190(10):2000–2014) use causal estimates from external data sources, such as clinical trials, to adjust CPMs for treatment drop-in. This represents a pragmatic and promising approach to address this issue, and it illustrates the value of utilizing causal inference in prediction. Building causality into the prediction pipeline can also bring other benefits. These include the ability to make and compare hypothetical predictions under different interventions, to make CPMs more explainable and transparent, and to improve model generalizability. Enriching CPMs with causal inference therefore has the potential to add considerable value to the role of prediction in healthcare. Oxford University Press 2021-02-17 /pmc/articles/PMC8485150/ /pubmed/33595073 http://dx.doi.org/10.1093/aje/kwab030 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Invited Commentary Sperrin, Matthew Diaz-Ordaz, Karla Pajouheshnia, Romin Invited Commentary: Treatment Drop-in—Making the Case for Causal Prediction |
title | Invited Commentary: Treatment Drop-in—Making the Case for Causal Prediction |
title_full | Invited Commentary: Treatment Drop-in—Making the Case for Causal Prediction |
title_fullStr | Invited Commentary: Treatment Drop-in—Making the Case for Causal Prediction |
title_full_unstemmed | Invited Commentary: Treatment Drop-in—Making the Case for Causal Prediction |
title_short | Invited Commentary: Treatment Drop-in—Making the Case for Causal Prediction |
title_sort | invited commentary: treatment drop-in—making the case for causal prediction |
topic | Invited Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485150/ https://www.ncbi.nlm.nih.gov/pubmed/33595073 http://dx.doi.org/10.1093/aje/kwab030 |
work_keys_str_mv | AT sperrinmatthew invitedcommentarytreatmentdropinmakingthecaseforcausalprediction AT diazordazkarla invitedcommentarytreatmentdropinmakingthecaseforcausalprediction AT pajouheshniaromin invitedcommentarytreatmentdropinmakingthecaseforcausalprediction |